IL6 and Behcet disease: In our hands, treatment with either IL-6 or IL-10 did not induce changes in plasma levels of glucose, insulin, or lipid profile parameters (including HDL, LDL, triglycerides, and cholesterol) from recipients transplanted after 4 h of reperfusion, when compared with animals without treatment (that is, BD+IL-6+LT and BD+IL-10+LT vs. BD+LT) with steatotic and non-steatotic liver grafts from DBDs (data not shown).